Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty

被引:0
作者
Ju Tang
Wei Zhu
Xiaoliang Mei
Zhenxiang Zhang
机构
[1] Taizhou People’s Hospital,Department of Joint Surgery
[2] Medical School of Nantong University,undefined
来源
Journal of Orthopaedic Surgery and Research | / 13卷
关键词
Total hip arthroplasty; Deep vein thrombosis; Plasminogen activator inhibitor-1; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 139 条
[1]  
Dua A(2017)National trends in deep vein thrombosis following total knee and total hip replacement in the United States Ann Vasc Surg 38 310-314
[2]  
Desai SS(2008)Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 381S-453S
[3]  
Lee CJ(2011)Incidence of deep vein thrombosis following total hip arthroplasty: a Doppler ultrasonographic study J Orthop Surg (Hong Kong) 19 50-53
[4]  
Heller JA(2010)Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty Thromb Res 126 e323-e326
[5]  
Geerts WH(2009)Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery Int J Hematol 89 572-576
[6]  
Bergqvist D(2010)Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism Thromb Res 125 S62-S65
[7]  
Pineo GF(2016)Elevated d-Dimer is not predictive of symptomatic deep venous thrombosis after total joint Arthroplasty J Arthroplast 31 2269-2272
[8]  
Heit JA(2000)Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice Blood 95 577-580
[9]  
Samama CM(1992)Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation N Engl J Med 327 1729-1733
[10]  
Lassen MR(1991)A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1 Blood 77 528-532